Keep On Keep Up Bladder Health: Co-creating and Testing a Self-management Technological Solution for Ageing Well

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-100
SponsorUniversity of Vic - Central University of Catalonia

About this trial

KOKU Bladder aims to develop and test an evidence based digital health program with behavior change techniques to improve bladder health of adults aged 50 and over. A novel module embedded in the approved app "Keep-on-Keep-up" (KOKU) will be co-created with end-users, researchers, health professionals, and stakeholders through a participatory and appreciative action and reflection methodology. After a comprehensive literature review and consultation with 4-6 experts, 6 focus groups will be undertaken in Kaunas(Lithuanian), Catalonia (Spain) and Manchester (UK) to co-create the contents of the module. Data will be analyzed using thematic analysis. Gamification and the Honeycomb model for user experience will be followed to achieve an appropriate technological solution that will be tested through a randomized controlled trial with at least 120 individuals. A mixed methods approach (quantitative/qualitative analysis) will be used to assess the feasibility and acceptability of the program. Open data and science, gender and ethical aspects, as well as a risk management plan are considered. A plan for communication, dissemination, exploitation of results will be considered. KOKU Bladder will be highly scalable and will have wide reach and impact. This proposal is in line with EU policy initiatives on Active and Healthy Ageing (bladder health and continence will be promoted), targeting aspects such as eHealth, Innovation and Digital Care Transformation, by supporting users to demand more responsive and integrated care programs for chronic conditions and enhancing self-management strategies, independence and health intelligence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥50 (range used in the literature covering the late-life process, including prostate issues and the perimenopause period)

Self-reported UI (at least 1 leakage/month)

Ability to read and understand the national languages

Have a mobile phone/tablet

Disqualifiers

Red-flag symptoms (e.g., bleeding)

Unstable health conditions.

Trial design

Design model

Parallel

Treatments tested in this trial

  • KOKU Bladder

    Behavioral

    In this intervention the participants will receive treatment with the KOKU app ( based digital health program with behavior change techniques to improve bladder health ) for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.

  • recommendations

    Behavioral

    In this intervention the participants will receive recommendations for self- managing urinary symptoms, which they must follow for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: control groupActive comparator 1 intervention
Group B: intervention groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

To co-create, develop and test an evidence based digital health program with behavior change techniques to decrease UI of community-dwelling adults aged 50 and over

The primary aim of KOKU Bladder is to co-create and test an eHealth program to address bladder health (specifically urinary incontinence) in community-dwelling adults aged 50 and over

Time frame
3 years

Secondary outcomes

1

To evaluate the life-impact related to UI (Incontinence Impact Questionnaire-7) of community-dwelling adults aged 50 and over.

We will use the Incontinence Impact Questionnaire-7 (IIQ-7) to assess it

Time frame
3 years
2

To evaluate the lower urinary tract symptoms (International Prostate Symptom Score) of community-dwelling adults aged 50 and over.

We will use different questionnaires.

Time frame
3 years
3

To evaluate the Patient Global Impression of Improvement; SB (visual analogue scale, a 7-day recall period) of community-dwelling adults aged 50 and over

We will use a visual analogue scale to assess it

Time frame
3 years
4

To evaluate the satisfaction with treatment of community-dwelling adults aged 50 and over.

We will use different questionnaires.

Time frame
3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Vic - Central University of Catalonia

Lead sponsor

Hospital Universitari Santa Maria, Spain

Collaborator

Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS)

Collaborator

University of Manchester

Collaborator

Research Council of Lithuania

Collaborator

Lithuanian Sports University

Collaborator

Agencia Gestió Ajuts Universitaris i Recerca

Collaborator

Consorci Hospitalari de Vic (CHV)

Collaborator